SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-086423
Filing Date
2020-07-24
Accepted
2020-07-24 16:05:45
Documents
1
Period of Report
2020-07-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2025480-2_4.html 4  
1 OWNERSHIP DOCUMENT tm2025480-2_4.xml 4 3109
  Complete submission text file 0001104659-20-086423.txt   4595
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 9620 MEDICAL CENTER DRIVE, SUITE 300 ROCKVILLE MD 20850
Business Address
Zhang Larry (Reporting) CIK: 0001754903 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 201047010